About IAC
A-Z Index
Immunization Action Coalition

Vaccine-Related Journal Articles

Diseases and Vaccines: Pertussis

Anthrax Influenza (variant) PCV Smallpox
Diphtheria Influenza (seasonal) PPSV Tetanus
Hib Measles Polio Varicella
Hepatitis A Meningococcus Rabies Zoster
Hepatitis B Mumps Rotavirus  
HPV Pertussis Rubella  
Recent pertussis articles
Pertussis 2003
Trends in Pertussis Among Infants in the United States, 1980-1999
Authors: Tanaka M, Vitek CR, Pascual FB, et al
Source: JAMA, December 10, 2003, Vol. 290(22):2968-2975
Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact
Authors: Skowronski DM, Remple VP, Macnabb J, et al
Source: Pediatrics, December 2003, Vol. 112(6 Pt 1):e453
Predictors of Death in Infants Hospitalized with Pertussis: A Case-control Study of 16 Pertussis Deaths in Canada
Authors: Mikelova LK, Halperin SA, Scheifele D, et al
Source: J Pediatr, November 2003, Vol. 143(5): 576-581
Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT
Authors: Le Saux N, Barrowman NJ, Moore DL, et al
Source: Pediatrics, November 2003, Vol. 112(5):e348-e353
Clinical Presentation of Pertussis in Unvaccinated and Vaccinated Children in the First Six Years of Life
Authors: Tozzi AE, Ravà L, Ciofi degli Atti ML, Salmasa S
Source: Pediatrics, November 2003, Vol. 112(5):1069-1075
Notice to Readers: FDA Approval of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, (INFANRIX®) for Fifth Consecutive DTaP Vaccine Dose
Source: MMWR, September 26, 2003, Vol. 52(38):921
The Pertussis Vaccine Controversy in Great Britain, 1974-1986
Author: Baker JP
Source: Vaccine, September 8, 2003, Vol. 21(25-26):4003-4010
Severe and Unrecognised: Pertussis in UK Infants
Authors: Crowcroft NS, Booy R, Harrison T, et al
Source: Arch Dis Child, September 2003, Vol. 88(9):802-806
Extensive Swelling Reactions Occurring After Booster Doses of Diphtheria-tetanus-acellular pertussis Vaccines
Author: Rennels MB
Source: Semin Pediatr Infect Dis, July 2003, Vol. 14(3):196-198
Increase in Deaths from Pertussis Among Young Infants in the United States in the 1990s
Authors: Vitek CR, Pascual FB, Baughman AL, et al
Source: Pediatr Infect Dis J., July 2003, Vol. 22(7):628-635
How Best to Estimate the Global Burden of Pertussis?
Authors: Crowcroft NS, Stein C, Duclos P, et al
Source: The Lancet Infectious Diseases, July 2003, Vol. 3(7):413-418
Effects of Pertussis Vaccination on Transmission: Vaccine Efficacy for Infectiousness
Authors: Preziosi MP, Halloran ME
Source: Vaccine, May 16, 2003, Vol. 21(17-18):1853-1861
Declining Pertussis Incidence in Sweden Following the Introduction of Acellular Pertussis Vaccine
Authors: Olin P, Gustafsson L, Barreto L, et al
Source: Vaccine, May 16, 2003, Vol. 21(17-18):2024-30
Systematic Review of the Effects of Pertussis Vaccines in Children
Authors: Jefferson T, Rudin M, DiPietrantonj C
Source: Vaccine, May 16, 2003, Vol. 21(17-18):2012-23
Clarification: Vol. 52, No. 10
Source: MMWR, April 25, 2003, Vol. 52(16):379
Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX(tm)) for Use in Infants
Source: MMWR, March 14, 2003, Vol. 52(10):203-4
Pertussis Outbreak Among Adults at an Oil Refinery--Illinois, August-October 2002
Source: MMWR, January 10, 2003, Vol. 52(1):1-4
Pertussis Resurgence in Canada Largely Caused by a Cohort Effect
Authors: Ntezayabo B, De Serres G, Duval B
Source: Pediatr Infect Dis J, January 2003, Vol. 22(1):22-27
back to top
Pertussis 2002
Pertussis of Adults and Infants
Authors: Wirsing von Konig CH, Halperin S, Riffelmann M, et al
Source: The Lancet Infectious Diseases, December 2002, Vol. 2:744-750
Timeliness of Childhood Immunizations
Authors: Luman ET, McCauley MM, Stokley S, Chu SY, Pickering LK
Source: Pediatrics, November 2002, Vol. 110(5):935-9
Patterns of Susceptibility in an Outbreak of Bordetella Pertussis: Evidence from a Community-Based Study
Authors: Moore DM, Mathias RG
Source: The Canadian Journal of Infectious Diseases, September/October 2002, Vol. 13(5):305-10
Bucking the Herd
Author: Allen A
Source: The Atlantic Monthly, September 2002
Impact of Vaccine Shortage on Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Coverage Rates Among Children Aged 24 Months - Puerto Rico, 2002
Source: MMWR, August 2, 2002, Vol. 51(30):667-668
Pertussis Deaths --- United States, 2000
Source: MMWR, July 19, 2002, Vol. 51(28):616-18
Effectiveness of Acellular Pertussis Vaccine Assessed by Hospital-Based Active Surveillance in Germany
Authors: Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G
Source: Clinical Infectious Diseases, July 15, 2002, Vol. 35(2):162-7
Notice to Readers: Resumption of Routine Schedule for Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine and for Measles, Mumps, and Rubella Vaccine
Source: MMWR, July 12, 2002, Vol. 51(27):598-9
Notice to Readers: Food and Drug Administration Approval of a Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children --- United States, 2002
Source: MMWR, July 5, 2002, Vol. 51(26):574
Lack of Consistent Relationship between Quantity of Aluminum in Diphtheria-Tetanus-Acellular Pertussis Vaccines and Rates of Extensive Swelling Reactions
Authors: Rennels M, Deloria M, Pichichero M, et al
Source: Vaccine, May 31, 2002, Vol. 20 (S3):S44-S47
Invited Commentary: Pertussis, A Forgotten Killer
Author: Duclos P, Olive JM
Source: American Journal of Epidemiology, May 15, 2002, Vol. 155(10):897-8
The Changing Age and Seasonal Profile of Pertussis in Canada
Authors: Skowronski DM, De Serres G, MacDonald D, et al
Source: Journal of Infectious Diseases, May 15, 2002, Vol. 185(10):1448-1453
Public Health Dispatch: Pertussis in an Infant Adopted from Russia --- May 2002
Source: MMWR, May 10, 2002, Vol. 51(18):394-5
Interchangeability of 2 Diphtheria-Tetanus-Acellular Pertussis Vaccines in Infancy
Authors: Greenberg DP, Pickering LK, Senders SD, et al
Source: Pediatrics, April 2002, Vol. 109(4):666-72
Pertussis in a Military and Military Beneficiary Population: Case Series and Review of the Literature
Authors: Christopher FL, Hepburn MJ, Frolichstein RA
Source: Military Medicine, March 2002, Vol. 167(3):215
Pertussis --- United States, 1997-2000
Source: MMWR, February 1, 2002, Vol. 51(4):73-6
back to top
Pertussis 2001-1997
Pertussis: A Continuing Hazard for Healthcare Facilities
Authors: Weber DJ, Rutala WA
Source: Infection Control and Hospital Epidemiology, December 2001, Vol. 22:736-740
Pertussis Outbreak in an Elementary School with High Vaccination Coverage
Authors: Khetsuriani N, Bisgard K, Prevots DR, et al
Source: Pediatric Infectious Diseases, December 2001, Vol. 20(12):1108-12
Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and Adolescents
Authors: Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B and the Sentinel Health Unit Surveillance System Pertussis Working Group
Source: Clinical Infectious Diseases, June 15, 2001, Vol. 32(12):1691-7
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series: Supplemental Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, November 17, 2000, Vol. 49(RR-13):1-8
Infant Immunization With Acellular Pertussis Vaccines in the United States: Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAERS)
Authors: Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS and the VAERS Working Group
Source: Pediatrics, October 2000, Vol. 106(4):E51
Hypotonic-Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998
Authors: DuVernoy TS, Braun MM, and the VAERS Working Group
Source: Pediatrics, October 2000, Vol. 106(4):1-9
Morbidity of Pertussis in Adolescents and Adults
Authors: De Serres G, Shadmani R, Duval B, et al
Source: The Journal of Infectious Diseases, July 2000, Vol. 182(1):174-9
Hypertrophic Pyloric Stenosis in Infants Following Pertussis Prophylaxis with Erythromycin -- Knoxville, Tennessee, 1999
Source: MMWR, December 17, 1999, Vol. 48(49):1117-1120
Comparison of a Fifth Dose of a Five-Component Acellular or a Whole Cell Pertussis Vaccine in Children Four to Six Years of Age
Authors: Halperin SA, Scheifele D, Barreto L, et al
Source: Pediatric Infectious Diseases, September 1999, Vol. 18(9):772-9
Pertussis in Adults: Epidemiology, Signs, Symptoms, and Implications for Vaccination
Author: Orenstein WA
Source: Clinical Infectious Diseases, June 1999, Vol. 28(S2)
Combination Vaccines for Childhood Immunization
Source: MMWR, May 14, 1999, Vol. 48(RR05):1-15
Clinical Manifestations of Bordetella pertussis Infection in Immunized Children and Young Adults
Authors: Yaari E, Yafe-Zimerman Y, Schwartz SB, et al
Source: Chest, May 1999, Vol 115(5):1254-8
Pertussis Vaccination and Wheezing Illnesses in Young Children: Prospective Cohort Study
Authors: Henderson J, North K, Griffiths M, Harvey I, Golding J and the Avon Longitudinal Study of Pregnancy and Childhood Team
Source: British Medical Journal, May 1, 1999, Vol. 318:1173-6
Acellular Pertussis Vaccines in Adults
Authors: Keitel WA, Edwards KM
Source: Infectious Disease Clinics of North America, March 1999, Vol. 13(1):83-94
Whooping Cough Caused by Bordetella pertussis and Bordetella parapertussis in an Immunized Population
Authors: He Q, Vijanen MK, Arvilmmi H, Aittanen B, Mertsola J
Source: JAMA, August 19, 1998, Vol. 280(7):635-7
Impact of Anti-Vaccine Movements on Pertussis Control: The Untold Story
Authors: Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, Chen RT
Source: The Lancet, January 31, 1998, Vol. 351(9099):356-361
Pertussis Outbreak -- Vermont, 1996
Source: MMWR, September 5, 1997, Vol. 46(35):822-6
Pertussis Vaccination: Use of Acellular Pertussis Vaccines Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 28, 1997, Vol. 46(RR-7):1-25
back to top
Pertussis 1996-1991
Notice to Readers FDA Approval of a Haemophilus b Conjugate Vaccine Combined by Reconstitution with an Acellular Pertussis Vaccine
Source: MMWR, November 15, 1996, Vol. 45(45):993-5
Notice to Readers Food and Drug Administration Approval of an Acellular Pertussis Vaccine for the Initial Four Doses of the Diphtheria, Tetanus, and Pertussis Vaccination Series
Source: MMWR, August 9, 1996, Vol. 45(31):676-7
Pertussis -- United States, January 1992-June 1995
Source: MMWR, July 21, 1995, Vol. 44(28):525-9
Epidemiologic Notes and Reports: Transmission of Pertussis from Adult to Infant -- Michigan, 1993
Source: MMWR, February 3, 1995, Vol. 44(04):74-6
Epidemiologic Notes and Reports: Erythromycin-Resistant Bordetella pertussis -- Yuma County, Arizona, May-October 1994
Source: MMWR, November 11, 1994, Vol. 43(44):807-810
Resurgence of Pertussis -- United States, 1993
Source: MMWR, December 17, 1993, Vol. 42(49):952-3,959-960
Food and Drug Administration Approval of Use of Haemophilus influenzae Type b Conjugate Vaccine Reconstituted with Diphtheria-Tetanus-Pertussis Vaccine for Infants and Children
Source: MMWR, December 17, 1993, Vol. 42(49)
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR, September 17, 1993, Vol. 42(RR-13):1-22
FDA Approval of Use of a New Haemophilus b Conjugate Vaccine and a Combined Diphtheria-Tetanus-Pertussis and Haemophilus b Conjugate Vaccine for Infants and Children
Source: MMWR, April 23, 1993, Vol. 42(15):296-8
Pertussis Outbreaks -- Massachusetts and Maryland, 1992
Source: MMWR, March 26, 1993, Vol. 42(11):197-200
Food and Drug Administration Approval of a Second Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine
Source: MMWR, August 28, 1992, Vol. 41(34):630-1
DTP: Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR, August 8, 1991, Vol. 40(RR-10):1-28
back to top
Recent Pertussis Articles
Pertussis journal articles 2007-2004
This page was updated on January 15, 2016.
This page was reviewed on December 30, 2015.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.